ArticleThe Journal of experimental medicine1997

TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation.

S Y Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.